We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Tell Me About It

By CLN Stat
Posted on 14 Dec 2020
Special session talk show highlights novel machine learning algorithm that incorporates serial hs-cTn measurements, other inputs to estimate emergency patients’ risk of myocardial infarction.

A talk show at the 2020 AACC Annual Scientific Meeting & Clinical Lab Expo highlights the experiences of two scientists who applied a machine learning algorithm to predict patients’ likelihood of myocardial infarction (MI). More...
Fred Apple, PhD, DABCC, and Yader Sandoval, MD, FACC, FSCAI, will discuss their findings during this special session at 3 p.m. (U.S. Central Standard Time) on December 13.

This algorithm, designated as the myocardial-ischemia-injury-index (MI3), was developed by Abbott Diagnostics under the patent #US2017/0296085 A1, said Apple, medical director of clinical laboratories, clinical chemistry, clinical and forensic toxicology, and point-of-care testing at Hennepin Healthcare in Minneapolis. Investigators would use this in patients with suspected MI to reflect an individual’s likelihood of having a type 1 MI.

Use of data analytics in laboratory medicine is a key area of AACC’s strategic plan. The 2020 Annual Meeting Organizing Committee (AMOC) “felt it would be of interest to have an interactive talk show format presentation on how algorithms can help providers utilize laboratory testing results and improve patient outcomes,” explained AMOC Chair Paul Jannetto, PhD, DABCC, FAACC. Historically, a time gap has existed between AACC University sessions on Sunday and Annual Scientific Meeting opening plenary.

AMOC added this timely interactive session on machine learning and MI for this unique time slot, he added.

Apple, Sandoval—an interventional cardiologist and senior associate consultant at the Mayo Clinic in Rochester, Minnesota—and others have been studying the MI3 algorithm in suspected type 1 MI, type 2 MI, and nonischemic myocardial injury patients presenting at emergency departments. “It incorporates ‘age, sex, and serial high-sensitivity cardiac troponin (hs-cTn) concentrations’ using gradient boosting to compute a value between 0 and 100 to reflect an individual’s likelihood of MI or no MI,” said Apple.

This allows for an individualized and objective assessment to identify low- and high-risk patients to assist in early patient management, he continued.

At this point, interested labs would have to contact Abbott to request use of the algorithm, and only for research purposes, clarified Apple. As far as he and his colleagues are aware, the U.S. Food and Drug Administration has not cleared it for use in patients, nor has it received the Conformitè Europëenne mark. “Investigators are studying MI3 against established early hs-cTn monitoring to determine its independent benefit compared to current early rule-out/rule-in protocols used globally,” noted Apple.

Physicians, pathologists, PhD scientists, laboratory directors, technologists, and in vitro diagnostic industry scientists are encouraged to attend this session. Participants will “come away with an education regarding a new and exciting concept that may provide a new ‘personalized laboratory medicine’ tool to help manage patients with the goal of improving outcomes,” said Apple.

This special session takes place on December 13 from 3–4 p.m. U.S. Central Standard Time and is worth 1 ACCENT credit.

Related Links:
AACC’s Annual Meeting Talk Show Machine Learning and MI
2020 AACC Annual Scientific Meeting & Clinical Lab Expo

New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Capillary Blood Collection Tube
IMPROMINI M3
New
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: A diagnostic test can distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone (Photo courtesy of University of Turku)

Novel Diagnostic Tool to Revolutionize Treatment Guidance of Head and Neck Cancer

Head and neck squamous cell carcinoma (HNSCC) is a solid tumor type commonly treated with surgery. However, there has been no clinically available method to determine which patients can be cured with surgery... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Microbiology

view channel
Image: The groundbreaking salmonella antimicrobial resistance prediction platform has demonstrated 95% accuracy (Photo courtesy of Yujie You et al., DOI: 10.1016/j.eng.2025.01.013)

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance

Antimicrobial-resistant Salmonella strains are a growing public health concern due to the overuse of antimicrobials and the rise of genetic mutations. Accurate prediction of resistance is crucial for effective... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.